30 October 2025
Bold Ideas, Bright Futures: Brilliance in Medical Affairs was the theme of this year’s joint Medical Affairs Professionals of Australasia (MAPA) and Medical Affairs Professional Society (MAPS) Australasia Medical Affairs Summit. The 2-day meeting was held on 24 and 25 September in Sydney, Australia, and welcomed over 300 attendees and 75 faculty members.
Media brand Medical Marketing and Media (MM+M) has listed Oxford PharmaGenesis in the latest Agency 100 – the annual definitive ‘who’s who’ ranking of the sector’s top healthcare marketing firms in North America.
Oxford PharmaGenesis is helping to raise public awareness of the importance of patient diversity in clinical trials through a campaign partnership with the non-profit organization Center for Information and Study on Clinical Research Participation (CISCRP).
Oxford PharmaGenesis continues to boost colleagues’ skills and expertise through a wide range of professional and personal development sessions offered to celebrate Learning at Work Week 2021 (17–23 May).
Monday 10 May to Wednesday 12 May A focus of the 2021 Clinical Data Disclosure, Transparency and Plain Language Summaries virtual conference was on the forthcoming implementation of the EU Clinical Trial Regulation (EU CTR) and the launch of the Clinical Trial Information Service (CTIS). However, the important role of different forms of plain language…
Oxford PharmaGenesis is delighted to have supported the publication of a Delphi consensus manuscript in the Journal of the American Society of Nephrology. The publication highlights the need to increase awareness among key stakeholders of racial health disparities in kidney disease and of APOL1-associated nephropathy.
Oxford PharmaGenesis has made its first appointments to the new role of Director of Innovation, created specifically to support teams across the global organization in utilizing new and emerging technology to support their clients’ unmet needs.
